Program
Please Note: All session times for the 13th AACR-JCA Joint Conference: From Cancer Discovery Science to Therapeutic Innovation are U.S. Hawaii–Aleutian Daylight (HDT).
Saturday, February 1
Sunday, February 2
- Plenary Session 1: Advances in Cancer Genomics
- Plenary Session 2: Cancer Immune Interaction
- Plenary Session 3: Cancer Evolution and the Tumor Microenvironment
Monday, February 3
- Plenary Session 4: Genome Instability
- Plenary Session 5: Cancer Plasticity and Resistance
- Plenary Session 6: New Treatment Modalities
Tuesday, February 4
- Plenary Session 7: Cancer Metabolism
- Plenary Session 8: Population Sciences
- Plenary Session 9: Novel Clinical Trials Platforms
Wednesday, February 5
- Plenary Session 10: Novel Roles of RNA in Cancer
- Plenary Session 11: Data Science
- Plenary Session 12: Novel Immunotherapies
Welcome and keynotes
6-8 p.m.
- Hiroyuki Mano, National Cancer Center, Tokyo, Japan
- Catherine J. Wu, Dana-Farber Cancer Institute, Boston, Massachusetts
Opening reception
8-9:30 p.m.
Continental Breakfast and “networking Roundtables”
7-8 a.m.
Plenary Session 1: Advances in Cancer Genomics
8-8:30 a.m.
- Yasuhiro Murakawa, Kyoto University, Kyoto, Japan,
- Hiromichi Suzuki, National Cancer Center Japan, Kyoto, Japan
- Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, Texas
Break
9:30-10 a.m.
Plenary Session 2: Cancer Immune Interaction
10-11:30 a.m.
- Hiroyoshi Nishikawa, Kyoto University, Kyoto, Japan
- Elham Azizi, Columbia University, New York, New York
- Livnat Jerby, Stanford University, Stanford, California
Free time
11:30 a.m.-4 p.m.
Plenary Session 3: Cancer Evolution and the Tumor Microenvironment
4-5:30 p.m.
- Sheila A. Stewart, Washington University in St. Louis, St. Louis, Missouri
- Nobuyuki Kakiuchi, Kyoto University, Kyoto, Japan
- Yoku Hayakawa, The University of Tokyo, Tokyo, Japan
poster session a
5:30-7:30 p.m.
Continental Breakfast and “Networking Roundtables”
7-8 a.m.
Plenary Session 4: Genome Instability
8-9:30 a.m.
- Ashok Venkitaraman, Cancer Science Institute of Singapore, Singapore
- Ivana Bozic, University of Washington, Seattle, Washington
- Alberto Ciccia, Columbia University, New York, New York
Break
9:30-10 a.m.
Plenary Session 5: Cancer Plasticity and Resistance
10-11:30 a.m.
- Noriko Gotoh, Kanazawa University, Kanazawa, Japan
- Laura D. Attardi, Stanford University, Stanford, California
- Tuomas Tammela, Memorial Sloan Kettering, New York, New York
free time
11:30 a.m.-4 p.m.
Plenary Session 6: New Treatment Modalities
4-5:30 p.m.
- Nathaneal S. Gray, Stanford University, Stanford, California
- Mika Kamata-Sakurai, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
- Pietro Genovese, Dana-Farber Cancer Institute, Massachusetts
Poster session B
5:30-7:30 p.m.
Continental Breakfast and “Networking Roundtables”
7-8 a.m.
Plenary Session 7: Cancer Metabolism
8-9:30 a.m.
- Marcia C. Haigis, Harvard Medical School, Boston, Massachusetts
- Kenji Chamoto, Kyoto University, Kyoto, Japan
- Ana P. Da Silva Gomes, H. Lee Moffitt Cancer Center, Tampa, Florida
Break
9:30-10 a.m.
Plenary Session 8: Population Sciences
10-11:30 a.m.
- Elizabeth A. Platz, Johns Hopkins University, Baltimore, Maryland
- Tomotaka Ugai, Harvard Medical School, Boston, Massachusetts
- Keitaro Matsuo, Aichi Cancer Center, Aichi, Japan
Free time
11:30 a.m.-4 p.m.
Plenary Session 9: Novel Clinical Trials Platforms
4-5:30 p.m.
- Takashi Owa, Eisai Inc., Nutley, New Jersey
- Naoya Harada, Daiichi Sankyo, Tokyo, Japan
- Naoto Ueno, University of Hawaii Cancer Center, Honolulu, Hawaii
Poster Session C
5:30-7:30 p.m.
Continental Breakfast and “Networking Roundtables”
7-8 a.m.
Plenary Session 10: Novel Roles of RNA in Cancer
8-9:30 a.m.
- Akiko Takahashi, Japanese Foundation for Cancer Research, Tokyo, Japan
- Akihide Yoshimi, National Cancer Center Japan, Tokyo, Japan
- Additional speaker to be announced
Break
9:30-10 a.m.
Plenary Session 11: Data Science
10-11:30 a.m.
- Benjamin Haibe-Kains, University of Toronto, Toronto, Ontario, Canada
- Jorge S. Reis-Filho, AstraZeneca, Gaithersburg, Massachusetts
- Shumpei Ishikawa, University of Tokyo, Tokyo, Japan
free time
11:30 a.m.-4 p.m.
Plenary Session 12: Novel Immunotherapies
4-5:30 p.m.
- Yuki Kagoya, Keio University School of Medicine, Tokyo, Japan
- Aude G. Chapuis, Fred Hutchinson Cancer Center, Seattle, Washington
- Additional speaker to be announced
Poster Session D
5:30-7:30 p.m.